Free Trial

Avanos Medical (AVNS) Competitors

Avanos Medical logo
$11.75 -0.08 (-0.68%)
As of 02:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AVNS vs. EYE, AORT, LMAT, LQDA, SSII, PRCT, ENOV, CDRE, NVCR, and CNMD

Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include National Vision (EYE), Artivion (AORT), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), SS Innovations International (SSII), PROCEPT BioRobotics (PRCT), Enovis (ENOV), Cadre (CDRE), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.

Avanos Medical vs. Its Competitors

National Vision (NASDAQ:EYE) and Avanos Medical (NYSE:AVNS) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

National Vision has a net margin of -0.75% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-0.75% 3.56% 1.49%
Avanos Medical -66.89%6.16%4.57%

National Vision currently has a consensus price target of $24.73, suggesting a potential downside of 3.78%. Given National Vision's stronger consensus rating and higher probable upside, research analysts plainly believe National Vision is more favorable than Avanos Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45
Avanos Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

National Vision has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500.

In the previous week, National Vision had 3 more articles in the media than Avanos Medical. MarketBeat recorded 6 mentions for National Vision and 3 mentions for Avanos Medical. National Vision's average media sentiment score of 1.22 beat Avanos Medical's score of 0.00 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avanos Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.2% of Avanos Medical shares are owned by institutional investors. 2.7% of National Vision shares are owned by insiders. Comparatively, 2.6% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

National Vision has higher revenue and earnings than Avanos Medical. National Vision is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.82B1.12-$28.50M-$0.18-142.78
Avanos Medical$687.80M0.79-$392.10M-$10.07-1.17

Summary

National Vision beats Avanos Medical on 12 of the 16 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVNS vs. The Competition

MetricAvanos MedicalMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$545.90M$7.57B$6.17B$21.98B
Dividend YieldN/A1.14%5.72%3.62%
P/E Ratio-1.1727.3129.6632.73
Price / Sales0.7927.80580.1581.53
Price / Cash0.9822.2737.1224.33
Price / Book0.655.2712.084.66
Net Income-$392.10M$178.09M$3.32B$1.02B
7 Day Performance2.26%-0.44%-0.29%1.57%
1 Month Performance-1.74%1.13%5.75%0.54%
1 Year Performance-47.43%2.98%65.71%12.89%

Avanos Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVNS
Avanos Medical
2.0095 of 5 stars
$11.75
-0.7%
N/A-47.6%$545.90M$687.80M-1.172,227News Coverage
Upcoming Earnings
EYE
National Vision
2.6668 of 5 stars
$25.49
-1.2%
$24.73
-3.0%
+165.5%$2.04B$1.82B-141.6113,411Positive News
AORT
Artivion
2.6971 of 5 stars
$42.53
+1.1%
$43.97
+3.4%
+63.7%$1.99B$388.54M-101.271,600
LMAT
LeMaitre Vascular
3.4558 of 5 stars
$88.01
+1.6%
$97.60
+10.9%
+3.2%$1.96B$219.86M42.72490
LQDA
Liquidia Technologies
3.6074 of 5 stars
$24.44
+8.7%
$32.38
+32.5%
+99.5%$1.94B$14M-14.3850Analyst Forecast
SSII
SS Innovations International
N/A$9.98
+2.5%
N/AN/A$1.89B$20.65M0.004
PRCT
PROCEPT BioRobotics
2.6942 of 5 stars
$34.72
+5.3%
$67.50
+94.4%
-48.5%$1.83B$274.95M-22.40430Upcoming Earnings
ENOV
Enovis
3.8064 of 5 stars
$32.41
+3.1%
$51.00
+57.4%
-18.2%$1.80B$2.11B-2.277,367News Coverage
CDRE
Cadre
3.1777 of 5 stars
$41.28
+1.4%
$37.50
-9.2%
+9.2%$1.65B$567.56M43.912,284Dividend Announcement
NVCR
NovoCure
4.0023 of 5 stars
$14.48
+5.1%
$27.50
+89.9%
-14.2%$1.54B$605.22M-9.281,488Upcoming Earnings
CNMD
CONMED
4.7888 of 5 stars
$47.85
+5.9%
$59.80
+25.0%
-22.5%$1.40B$1.31B13.553,900Positive News

Related Companies and Tools


This page (NYSE:AVNS) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners